DOCSLIB.ORG

Evaluation of Hematuria in Children Kevin E.C

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Evaluation of Hematuria in Children Kevin E.C Urol Clin N Am 31 (2004) 559–573 Evaluation of hematuria in children Kevin E.C. Meyers, MBBCh Division of Nephrology, Department of Pediatrics, Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, 34th Street and Civic Center Boulevard, Main Building, 2nd Floor, Philadelphia, PA 19104-4399, USA The detection of even microscopic amounts of Nine milliliters is decanted and the sediment blood in a child’s urine alarms the patient, is resuspended and an aliquot examined. The urine parents, and physician, and often prompts the is examined by microscopy by high power field performance of many laboratory studies. Hema- (hpf) that is 400Â magnification. Macroscopic turia is one of the most important signs of renal or hematuria often does not require concentration. bladder disease, but proteinuria is a more impor- Bright-red urine, visible clots, or crystals with tant diagnostic and prognostic finding, except in normal-looking red blood cells (RBCs) suggests the case of calculi or malignancies. Hematuria is bleeding from the urinary tract. Cola-colored almost never a cause of anemia. The physician urine, RBC casts, and deformed (dysmorphic) should ensure that serious conditions are not RBCs suggest glomerular bleeding [4]. An absence overlooked, avoid unnecessary and often expen- of RBCs in the urine with a positive dipstick re- sive laboratory studies, reassure the family, and action suggests hemoglobinuria or myoglobinuria. provide guidelines for additional studies if there is The sensitivity and specificity of the dipstick a change in the child’s course [1]. This article method for detecting blood in the urine vary. provides an approach to the evaluation and When tested on urine samples in which a prede- management of hematuria in a child [2,3]. Many termined amount of blood has been placed, dip- tests have been recommended for the child with sticks have a sensitivity of 100 and a specificity of hematuria, but no consensus exists on a stepwise 99 in detecting one to five RBCs/hpf [5]. This evaluation. Although more research is needed to corresponds to approximately 5 to 10 intact resolve certain controversies in management, the RBCs/lL urine [6]. There is no consensus on the suggested approach aims to detect major or definition of microscopic hematuria, although treatable problems and limit the anxiety, cost, more than 5 to 10 RBCs/hpf is considered and energy required by unnecessary testing. significant [7,8]. The author and others recom- mend that at least two of three urinalyses show microhematuria over 2 to 3 weeks before further Definitions evaluation is performed [3,9]. The American Academy of Pediatrics recommends a screening Macroscopic hematuria is visible to the naked urinalysis at school entry (4–5 years of age) and eye, but microscopic hematuria usually is detected once during adolescence (11–21 years of age) as by a dipstick test during a routine examination. a component of well child–care. Hematuria is confirmed by microscopic examina- tion of the spun urine sediment. Microscopic examination is performed with concentration of Incidence and prevalence the urinary sediment by centrifugation. Ten milli- liters of urine is spun at 2000 rpm for 5 minutes. Pediatricians frequently encounter hematuria in children. Macroscopic hematuria has an esti- mated incidence of 1.3 per 1000 [2]. Microscopic E-mail address: [email protected] hematuria, although more common than gross 0094-0143/04/$ - see front matter Ó 2004 Elsevier Inc. All rights reserved. doi:10.1016/j.ucl.2004.04.015 560 K.E.C. Meyers / Urol Clin N Am 31 (2004) 559–573 hematuria, has a variably reported incidence depending on the definition used for making the Box 1. Causes of hematuria in children diagnosis. The incidence of microscopic hematu- ria in schoolchildren was estimated at 0.41% Glomerular diseases when four urine samples per child were collected Recurrent gross hematuria (IgA and 0.32% in girls and 0.14% in boys when five nephropathy, benign familial consecutive urine specimens were analyzed over 5 hematuria, Alport’s syndrome) years [10,11]. Microscopic hematuria in two or Acute poststreptococcal more urine samples is found in 1% to 2% of glomerulonephritis children 6 to 15 years of age. Membranoproliferative glomerulonephritis Systemic lupus erythematosus Pathophysiology Membranous nephropathy Rapidly progressive Hematuria may originate from the glomeruli, glomerulonephritis renal tubules and interstitium, or urinary tract Henoch-Schonlein purpura (including collecting systems, ureters, bladder, and Goodpasture’s disease urethra) (Boxes 1 and 2). In children, the source of bleeding is more often from glomeruli than from Interstitial and tubular the urinary tract. RBCs cross the glomerular Acute pyelonephritis endothelial-epithelial barrier and enter the capil- Acute interstitial nephritis lary lumen through structural discontinuities in the Tuberculosis capillary wall. These discontinuities seem to be at Hematologic (sickle cell disease, the capillary wall–mesangial cell reflections [12].In coagulopathies von Willebrand’s most cases, proteinuria, RBC casts, and deformed disease, renal vein thrombosis, (dysmorphic) RBCs in the urine accompany he- thrombocytopenia) maturia caused by any of the glomerulonephriti- Urinary tract des. The renal papillae are susceptible to necrotic Bacterial or viral (adenovirus) injury from microthrombi and anoxia in patients infection–related with a hemoglobinopathy or in those exposed to Nephrolithiasis and hypercalciuria toxins. Patients with renal parenchymal lesions Structural anomalies, congenital may have episodes of transient microscopic or anomalies, polycystic kidney macroscopic hematuria during systemic infections disease or after moderate exercise. This may be the result Trauma of renal hemodynamic responses to exercise or Tumors fever by undetermined mechanisms. Exercise Medications (aminoglycosides, Initial evaluation amitryptiline, anticonvulsants, aspirin, chlorpromazine, coumadin, Macroscopic hematuria cyclophosphamide, diuretics, The evaluation of a child with gross hematuria penicillin, thorazine) differs from that of microscopic hematuria (Fig. 1). Macroscopic hematuria of glomerular origin usu- ally is described as brown, tea-colored, or cola- evaluate children with recurrent nonglomerular colored, whereas macroscopic hematuria from the macroscopic hematuria of undetermined origin lower urinary tract (bladder and urethra) is usually because cystoscopy may be warranted. pink or red. Macroscopic hematuria in the absence of significant proteinuria or RBC casts is an Microscopic hematuria indication for a renal and bladder ultrasound to exclude malignancy or cystic renal disease. Re- Microscopic hematuria, defined by more than ferral to a urologist is required when clinical five RBCs/hpf, almost always warrants referral to evaluation and workup indicates that there is a nephrologist rather than an urologist. Figs. 2 a tumor, a structural urogenital abnormality, or and 3 give an approach to the evaluation of an obstructing calculus. A urologist also should asymptomatic and symptomatic microscopic K.E.C. Meyers / Urol Clin N Am 31 (2004) 559–573 561 History Box 2. Causes of asymptomatic isolated microscopic hematuria A history of dysuria, frequency, urgency, or flank or abdominal pain suggests a diagnosis of Common urinary tract infection or nephrolithiasis. Recent Undetermined trauma, strenuous exercise, menstruation, or blad- Benign familial der catheterization may account for transient Idiopathic hypercalciuria hematuria. A sore throat or skin infection within IgA nephropathy the past 2 to 4 weeks directs the evaluation toward Sickle cell trait or anemia postinfectious glomerulonephritis. Drugs and Transplant toxins may cause either hematuria or hemoglobin- uria (Box 5). A careful family history must include Less common questions about hematuria, hearing loss, hyper- Alport nephritis tension, nephrolithiasis, renal diseases, renal cystic Postinfectious glomerulonephritis diseases, hemophilia, sickle cell trait, and dialysis Trauma or transplant. Exercise Nephrolithiasis Physical examination Henoch-Schonlein purpura The presence or absence of hypertension or Uncommon proteinuria helps to decide how extensively to Drugs and toxins pursue the diagnostic evaluation. If the blood Coagulopathy pressure is normal and the patient is passing Ureteropelvic junction obstruction normal amounts of urine, it is unlikely that Focal segmental glomerulosclerosis microscopic hematuria, whatever its cause, war- Membranous glomerulonephritis rants immediate treatment. If the blood pressure is Membranoproliferative elevated, the hematuria requires a more intensive glomerulonephritis diagnostic evaluation. The presence of fever or Lupus nephritis costovertebral angle tenderness may indicate a Hydronephrosis urinary tract infection. An abdominal mass may Pyelonephritis be caused by a tumor, hydronephrosis, multicystic Vascular malformation dysplastic kidney, or polycystic kidney disease. Tuberculosis Macroscopic hematuria with proteinuria suggests Tumor glomerulonephritis. Rashes and arthritis can occur in Henoch-Schonlein purpura and systemic lupus erythematosus. Edema is an important feature of (Adapted from Lieu TA, Grasmeder M, the nephrotic syndrome (Table 1). Kaplan BS. An approach to the evaluation and treatment of microscopic hematuria. Laboratory studies Pediatr Clin North Am 1991;38:579–92.) Only two diagnostic tests are required for a child with microscopic hematuria: (1) a test for proteinuria
Load more

Recommended publications
  • Oxalate Loading Test: a Screening Test for Steatorrhoea
    Gut: first published as 10.1136/gut.20.12.1089 on 1 December 1979. Downloaded from Gut, 1979, 20, 1089-1094 Oxalate loading test: a screening test for steatorrhoea D. S. RAMPTON', G. P. KASIDAS, G. ALAN ROSE, AND MARTIN SARNER2 From University College Hospital, London, St. Peter's Hospitals and Institute of Urology, London SUMMARY To investigate the possibility of measuring urinary oxalate output instead of faecal fat excretion as an outpatient screening test for steatorrhoea, we determined 24 hour urinary oxalate and five day faecal fat excretion before and during an oral load of sodium oxalate 600 mg daily (oxalate 4-44 mmol), in 32 patients with suspected malabsorption on a diet containing oxalate 30 mg (0-33 mmol), fat 50 g (180 mmol), and calcium 1 g (25 mmol). Nineteen patients proved to have steatorrhoea (mean faecal fat 62 mmol/24 h, range 19-186 mmol) of varying aetiologies. On the diet alone, urinary oxalate was raised in only nine of these patients (mean 0 25 mmol/24 h, range 0-08-059 mmol) (normal <0 20). By contrast, when the diet was supplemented with oral sodium oxalate, all 19 patients with steatorrhoea had hyperoxaluria (mean 0-91 mmol/24 h, range 046- 1P44 mmol) (normal <0-44). There was a significant positive linear relationship between urinary oxalate and faecal fat when the 32 patients were on the high oxalate intake (r=0*73, P <0.001), but not when they were on the low oxalate intake. Mean percentage absorption of orally administered oxalate was 58+09% (±1 SD) in normal subjects and 14-7+6-0% (P <0.002) in patients with steatorrhoea.
    [Show full text]
  • Guidelines for Management of Acute Renal Failure (Acute Kidney Injury)
    Guidelines for management of Acute Renal Failure (Acute Kidney Injury) Children’s Kidney Centre University Hospital of Wales Cardiff CF14 4XW DISCLAIMER: These guidelines were produced in good faith by the author(s) reviewing available evidence/opinion. They were designed for use by paediatric nephrologists at the University Hospital of Wales, Cardiff for children under their care. They are neither policies nor protocols but are intended to serve only as guidelines. They are not intended to replace clinical judgment or dictate care of individual patients. Responsibility and decision-making (including checking drug doses) for a specific patient lie with the physician and staff caring for that particular patient. Version 1, S. Hegde/Feb 2009 Guidelines on management of Acute Renal Failure (Acute Kidney Injury) Definition of ARF (now referred to as AKI) • Acute renal failure is a sudden decline in glomerular filtration rate (usually marked by rise in serum creatinine & urea) which is potentially reversible with or without oliguria. • Oliguria defined as urine output <300ml/m²/day or < 0.5 ml/kg/h (<1 ml/kg/h in neonates). • Acute on chronic renal failure suggested by poor growth, history of polyuria and polydipsia, and evidence of renal osteodystrophy However, immediately after a kidney injury, serum creatinine & urea levels may be normal, and the only sign of a kidney injury may be decreased urine production. A rise in the creatinine level can result from medications (e.g., cimetidine, trimethoprim) that inhibit the kidney’s tubular secretion. A rise in the serum urea level can occur without renal injury, such as in GI or mucosal bleeding, steroid use, or protein loading.
    [Show full text]
  • Current Current
    CP_0406_Cases.final 3/17/06 2:57 PM Page 67 Current p SYCHIATRY CASES THAT TEST YOUR SKILLS Chronic enuresis has destroyed 12-year-old Jimmy’s emotional and social functioning. The challenge: restore his self-esteem by finding out why can’t he stop wetting his bed. The boy who longed for a ‘dry spell’ Tanvir Singh, MD Kristi Williams, MD Fellow, child® Dowdenpsychiatry ResidencyHealth training Media director, psychiatry Medical University of Ohio, Toledo CopyrightFor personal use only HISTORY ‘I CAN’T FACE MYSELF’ during regular checkups and refer to a psychia- immy, age 12, is referred to us by his pediatri- trist only if the child has an emotional problem J cian, who is concerned about his “frequent secondary to enuresis or a comorbid psychiatric nighttime accidents.” His parents report that he wets disorder. his bed 5 to 6 times weekly and has never stayed con- Once identified, enuresis requires a thorough sistently dry for more than a few days. assessment—including its emotional conse- The accidents occur only at night, his parents quences, which for Jimmy are significant. In its say. Numerous interventions have failed, including practice parameter for treating enuresis, the restricting fluids after dinner and awakening the boy American Academy of Child and Adolescent overnight to make him go to the bathroom. Psychiatry (AACAP)1 suggests that you: Jimmy, a sixth-grader, wonders if he will ever Take an extensive developmental and family stop wetting his bed. He refuses to go to summer history. Find out if the child was toilet trained and camp or stay overnight at a friend’s house, fearful started walking, talking, or running at an appro- that other kids will make fun of him after an acci- priate age.
    [Show full text]
  • Blueprint Genetics Primary Hyperoxaluria Panel
    Primary Hyperoxaluria Panel Test code: KI0801 Is a 3 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of hyperoxaluria. About Primary Hyperoxaluria The primary hyperoxalurias are rare disorders of glyoxylate metabolism, which result in markedly increased endogenous oxalate synthesis by the liver. They are characterized by an excess of oxalate resulting in manifestations ranging from occasional renal stones, recurrent nephrolithiasis and nephrocalcinosis to end-stage renal disease (ESRD) and systemic oxalosis. Presenting ranges from the neonatal period to adulthood. Among disorders causing hyperoxaluria, the primary hyperoxalurias are the most severe, ultimately leading to ESRD and if untreated, death in most patients. Type I primary hyperoxaluria (PH1), is caused by deficient or absent activity of liver-specific peroxisomal alanine glyoxylate aminotransferase (AGT). In some patients with PH1 type disease, the enzyme is present but mistargeted to mitochondria where it is metabolically inactive. The severe infantile form is characterized by a failure to thrive, nephrocalcinosis with or without nephrolithiasis and early ESRD. Onset in childhood and adolescence is often characterized by recurrent urolithiasis (with or without nephrocalcinosis) and progressive renal failure. The late onset form is characterized by occasional renal stones with onset in adulthood, but acute renal failure caused by bilateral obstruction of the kidneys by oxalate stones may occur. Other manifestations include urinary tract infections, dysuria and hematuria. The ongoing systemic oxalosis also may lead to other clinical manifestations such as cardiac conduction defects, vascular calcification with distal gangrene, disturbed vision, specific brown colored retinal deposits, skin nodules, joint involvement and bone disease leading to fractures in long-term dialysis-dependent patients.
    [Show full text]
  • Pediatric Nephrology: Highlights for the General Practitioner
    International Journal of Pediatrics Pediatric Nephrology: Highlights for the General Practitioner Guest Editors: Mouin Seikaly, Sabeen Habib, Amin J. Barakat, Jyothsna Gattineni, Raymond Quigley, and Dev Desi Pediatric Nephrology: Highlights for the General Practitioner International Journal of Pediatrics Pediatric Nephrology: Highlights for the General Practitioner Guest Editors: Mouin Seikaly, Sabeen Habib, Amin J. Barakat, Jyothsna Gattineni, Raymond Quigley, and Dev Desi Copyright © 2012 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in “International Journal of Pediatrics.” All articles are open access articles distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Editorial Board Ian T. Adatia, USA Eduardo H. Garin, USA Steven E. Lipshultz, USA Uri S. Alon, USA Myron Genel, USA Doff B. McElhinney, USA Laxman Singh Arya, India Mark A. Gilger, USA Samuel Menahem, Australia Erle H. Austin, USA Ralph A. Gruppo, USA Kannan L. Narasimhan, India Anthony M. Avellino, USA Eva C. Guinan, USA Roderick Nicolson, UK Sylvain Baruchel, Canada Sandeep Gupta, USA Alberto Pappo, USA Andrea Biondi, Italy Pamela S. Hinds, USA Seng Hock Quak, Singapore Julie Blatt, USA Thomas C. Hulsey, USA R. Rink, USA Catherine Bollard, USA George Jallo, USA Joel R. Rosh, USA P. D. Brophy, USA R. W. Jennings, USA Minnie M. Sarwal, USA Ronald T. Brown, USA Eunice John, USA Charles L. Schleien, USA S. Burdach, Germany Richard A. Jonas, USA Elizabeth J. Short, USA Lavjay Butani, USA Martin Kaefer, USA V. C. Strasburger, USA Waldemar A. Carlo, USA F. J. Kaskel, USA Dharmapuri Vidyasagar, USA Joseph M.
    [Show full text]
  • This Thesis Has Been Submitted in Fulfilment of the Requirements for a Postgraduate Degree (E.G
    This thesis has been submitted in fulfilment of the requirements for a postgraduate degree (e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following terms and conditions of use: This work is protected by copyright and other intellectual property rights, which are retained by the thesis author, unless otherwise stated. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author. The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author. When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given. Endothelin‐1 antagonism in glomerulonephritis Elizabeth Louise Owen BSc. (Hons), MSc. A thesis submitted towards the degree of PhD The University of Edinburgh 2016 Declaration I declare that the work presented in this thesis is my own and has not previously been published or presented towards another higher degree except where clearly acknowledged as such in the text. ……………………………………… …………. Elizabeth Louise Owen Date Page | 2 Acknowledgements I would like to express my gratitude to my supervisor David Kluth for his support, guidance and efforts during my PhD; Bean, thankyou for your patience and input. Thankyou also to Jeremy Hughes and Simon Brown for your advice and input for the various aspects of labwork, presentations and general how to’s. Jason King, thanks for all your help in the lab, you were always my ‘go‐to‐guy’ for all things technical….and for your many cool pairs of trainers.
    [Show full text]
  • Paroxysmal Nocturnal Hemoglobinuria
    Paroxysmal nocturnal hemoglobinuria Description Paroxysmal nocturnal hemoglobinuria is an acquired disorder that leads to the premature death and impaired production of blood cells. The disorder affects red blood cells (erythrocytes), which carry oxygen; white blood cells (leukocytes), which protect the body from infection; and platelets (thrombocytes), which are involved in blood clotting. Paroxysmal nocturnal hemoglobinuria affects both sexes equally, and can occur at any age, although it is most often diagnosed in young adulthood. People with paroxysmal nocturnal hemoglobinuria have sudden, recurring episodes of symptoms (paroxysmal symptoms), which may be triggered by stresses on the body, such as infections or physical exertion. During these episodes, red blood cells are prematurely destroyed (hemolysis). Affected individuals may pass dark-colored urine due to the presence of hemoglobin, the oxygen-carrying protein in blood. The abnormal presence of hemoglobin in the urine is called hemoglobinuria. In many, but not all cases, hemoglobinuria is most noticeable in the morning, upon passing urine that has accumulated in the bladder during the night (nocturnal). The premature destruction of red blood cells results in a deficiency of these cells in the blood (hemolytic anemia), which can cause signs and symptoms such as fatigue, weakness, abnormally pale skin (pallor), shortness of breath, and an increased heart rate. People with paroxysmal nocturnal hemoglobinuria may also be prone to infections due to a deficiency of white blood cells. Abnormal platelets associated with paroxysmal nocturnal hemoglobinuria can cause problems in the blood clotting process. As a result, people with this disorder may experience abnormal blood clotting (thrombosis), especially in large abdominal veins; or, less often, episodes of severe bleeding (hemorrhage).
    [Show full text]
  • The Effect of Flood Diuresis on Hemo-Globinuria
    THE EFFECT OF FLOOD DIURESIS ON HEMO- GLOBINURIA. BY HERBERT HAESSLERj M.D. (From the Laboratories of The Rockefeller Inatitute for Medical Research.) (Received for publication, November 9, 1921.) The fact is well recognized that a considerable quantity of hemo- globin must be free in the plasma if any is to pass the renal barrier and appear in the urine. The pigment is, like dextrose, a "threshold substance." It readily penetrates into the renal tubules but is absorbed again more or less completely during its course through them. t This being true, diuresis should diminish the chances of absorption by hastening the flow of fluid, and tend to lead to the appearance of the pigment in the urine. Evidence will here be presented that such is the case. Hemoglobinuria, like glycosuria, is much favored by flood diuresis. Method. A concentrated solution of hemoglobin was abruptly thrown into the circulation of rabbits and dogs, followed in some instances by a slower injection of salt solution. The amount of pigment introduced was slightly less than that required to produce hemoglobinuria in the absence of diuresis. The urine was collected at intervals by catheter. All of the animals were males. Individuals were selected with normal kidneys, as indicated by ~e general character of the urine and proven by the autopsy findings. Great care was necessary to prevent hemorrhage during the catheterization of the rabbits, and despite it a few red cells were frequently encountered after- wards in the urine. For this reason the experiments were repeated on dogs, in which the complication can be avoided.
    [Show full text]
  • PDI Appendix G Intermediate-Risk Immunocompromised State Ef Ec2
    AHRQ QI™ ICD‐10‐CM/PCS Specification Enhanced Version 5.0 1 of 6 Pediatric Quality Indicators Appendices www.qualityindicators.ahrq.gov Pediatric Quality Indicators Appendices APPENDIX G: Intermediate-Risk Immunocompromised State Diagnosis Codes Intermediate-risk immunocompromised state diagnosis codes: (IMMUITD) ICD-9-CM Description ICD-10-CM Description 07022 VIRAL HEPATITIS B W HEPATIC COMA, CHRONIC WO B180 Chronic viral hepatitis B with delta‐agent MENTION OF HEPATITIS DELTA 07023 VIRAL HEPATITIS B W HEPACTIC COMA, CHRONIC W B181 Chronic viral hepatitis B without delta‐agent HEPATITIS DELTA 07044 CHRONIC HEPATITIS C WITH HEPACTIC COMMA B182 Chronic viral hepatitis C 2894 HYPERSPLENISM B520 Plasmodium malariae malaria with nephropathy 28950 DISEASE OF SPLEEN NOS D5702 Hb‐SS disease with splenic sequestration 28951 CHRONIC DIGESTIVE SPLENOMEGALY D57212 Sickle‐cell/Hb‐C disease with splenic sequestration 28952 SPLENIC SEQUESTRATION D57412 Sickle‐cell thalassemia with splenic sequestration 28959 OTHER DISEASE OF SPLEEN, OTHER D57812 Other sickle‐cell disorders with splenic sequestration 4560 ESOPHAGEAL VARICES W BLEEDING D730 Hyposplenism 4561 ESOPHAGEAL VARICES WO MENTION OF BLEEDING D731 Hypersplenism 45620 ESOPHAGEAL VARICES IN DISEASE CLASSIFIED D732 Chronic congestive splenomegaly ELSEWHERE, W BLEEDING 45621 ESOPHAGEAL VARICES IN DISEASE CLASSIFIED D733 Abscess of spleen ELSEWHERE, WO MENTION OF BLEEDING 5723 PORTAL HYPERTENSION D735 Infarction of spleen 5728 OTHER SEQUELAE OF CHRONIC LIVER DISEASE D7389 Other diseases of spleen 5735
    [Show full text]
  • Prevalence of Microhematuria in Renal Colic and Urolithiasis: a Systematic Review and Meta-Analysis
    Minotti et al. BMC Urology (2020) 20:119 https://doi.org/10.1186/s12894-020-00690-7 RESEARCH ARTICLE Open Access Prevalence of microhematuria in renal colic and urolithiasis: a systematic review and meta-analysis Bruno Minotti1* , Giorgio Treglia2, Mariarosa Pascale3, Samuele Ceruti4, Laura Cantini5, Luciano Anselmi5 and Andrea Saporito5 Abstract Background: This systematic review and meta-analysis aims to investigate the prevalence of microhematuria in patients presenting with suspected acute renal colic and/or confirmed urolithiasis at the emergency department. Methods: A comprehensive literature search was conducted to find relevant data on prevalence of microhematuria in patients with suspected acute renal colic and/or confirmed urolithiasis. Data from each study regarding study design, patient characteristics and prevalence of microhematuria were retrieved. A random effect-model was used for the pooled analyses. Results: Forty-nine articles including 15′860 patients were selected through the literature search. The pooled microhematuria prevalence was 77% (95%CI: 73–80%) and 84% (95%CI: 80–87%) for suspected acute renal colic and confirmed urolithiasis, respectively. This proportion was much higher when the dipstick was used as diagnostic test (80 and 90% for acute renal colic and urolithiasis, respectively) compared to the microscopic urinalysis (74 and 78% for acute renal colic and urolithiasis, respectively). Conclusions: This meta-analysis revealed a high prevalence of microhematuria in patients with acute renal colic (77%), including those with confirmed urolithiasis (84%). Intending this prevalence as sensitivity, we reached moderate values, which make microhematuria alone a poor diagnostic test for acute renal colic or urolithiasis. Microhematuria could possibly still important to assess the risk in patients with renal colic.
    [Show full text]
  • Screening for Urinary Incontinence
    SCREENING FOR URINARY INCONTINENCE RECOMMENDATION TO THE HEALTH RESOURCES AND SERVICES ADMINISTRATION DECEMBER 2017 © 2017 ACOG Foundation. All rights reserved. This project was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number UHOMC29940, Bright Futures for Women’s Health: Standard Practice Guidelines for Well Women Care. This information or content and conclusions are those of the author and should not be construed as the official position nor policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government. Screening for Urinary Incontinence: Recommendation to Health Resources and Services Administration was developed by the Multidisciplinary Steering Committee of the Women’s Preventive Services Initiative. These recommendations should not be viewed as a rigid body of rules. The recommendations are general and intended to be adapted to many different situations, taking into account the needs and resources particular to the locality, the institution, or the type of practice. Variations and innovations that improve the quality of patient care are encouraged rather than restricted. The purpose of these guidelines will be well served if they provide a firm basis on which local norms may be built. Evidence Summaries and systematic reviews are used with permission from Oregon Health & Science University. Copyright 2017 by the ACOG Foundation, 409 12th Street, SW, PO Box 96920, Washington, DC 20090-6920. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior written permission from the publisher.
    [Show full text]
  • Blood Or Protein in the Urine: How Much of a Work up Is Needed?
    Blood or Protein in the Urine: How much of a work up is needed? Diego H. Aviles, M.D. Disclosure • In the past 12 months, I have not had a significant financial interest or other relationship with the manufacturers of the products or providers of the services discussed in my presentation • This presentation will not include discussion of pharmaceuticals or devices that have not been approved by the FDA Screening Urinalysis • Since 2007, the AAP no longer recommends to perform screening urine dipstick • Testing based on risk factors might be a more effective strategy • Many practices continue to order screening urine dipsticks Outline • Hematuria – Definition – Causes – Evaluation • Proteinuria – Definition – Causes – Evaluation • Cases You are about to leave when… • 10 year old female seen for 3 day history URI symptoms and fever. Urine dipstick showed 2+ for blood and no protein. Questions? • What is the etiology for the hematuria? • What kind of evaluation should be pursued? • Is this an indication of a serious renal condition? • When to refer to a Pediatric Nephrologist? Hematuria: Definition • Dipstick > 1+ (large variability) – RBC vs. free Hgb – RBC lysis common • > 5 RBC/hpf in centrifuged urine • Can be – Microscopic – Macroscopic Hematuria: Epidemiology • Microscopic hematuria occurs 4-6% with single urine evaluation • 0.1-0.5% of school children with repeated testing • Gross hematuria occurs in 1/1300 Localization of Hematuria • Kidney – Brown or coke-colored urine – Cellular casts • Lower tract – Terminal gross hematuria – (Blood
    [Show full text]